Free Biopharma Daily Stock Updates - 09/03/21

$XBI $134 -2%

---

Covid Updates

$CYDY +3% CytoDyn to Hold Webcast on September 8 to Discuss Results from mTNBC Trials, HIV BLA Status, and Updates on COVID-19 and NASH Trials. source

Pipeline Updates

$PLRX -1% Pliant Therapeutics Announces Webcast to Present Interim Clinical Data from Ongoing Phase 2a PET Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis. source

$IMPL -19% Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine. source

$ARDX -1% Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial. source

$IONS -3% Ionis to host ATTR symposium highlighting CARDIO-TTRansform Study at 3rd European ATTR Amyloidosis meeting. source

$GKOS -1% Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™. source

$SUPN -1% Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA. source

$KLDO -5% Company received a Warning Letter from the U.S. Food and Drug Administration (FDA) for failure to submit an investigational new drug application (IND) prior to conducting two clinical studies, K031 and K032, of the Company’s MMT KB109 in subjects with COVID-19. source

Finance & Business Updates

$SAVA -8% Cassava Sciences Releases a Public Statement Regarding Recent Allegations. source

---

Posted by DV